JP Matthews

2.0k total citations
26 papers, 1.4k citations indexed

About

JP Matthews is a scholar working on Oncology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, JP Matthews has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in JP Matthews's work include Lymphoma Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (4 papers). JP Matthews is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (4 papers). JP Matthews collaborates with scholars based in Australia, United Kingdom and United States. JP Matthews's co-authors include M. Wolf, Jeff Szer, D. Joshua, R. M. Fox, G. A. R. Young, Ken Bradstock, Arno Enno, K. Yuen, RM Palmer and R. F. Wilson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

JP Matthews

25 papers receiving 1.3k citations

Peers

Countries citing papers authored by JP Matthews

Since Specialization

Citations

This map shows the geographic impact of JP Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JP Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JP Matthews more than expected).

Fields of papers citing papers by JP Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JP Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JP Matthews. The network helps show where JP Matthews may publish in the future.

Co-authorship network of co-authors of JP Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of JP Matthews. A scholar is included among the top collaborators of JP Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JP Matthews. JP Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma 2004 ·Leukemia & lymphoma ·(unknown), (unknown), Callum Smith, Ehtesham Abdi, Michael F. Leahy, Carla I. Falkson, M Wolf, Henry Januszewicz, J.F. Seymour, Kristy L. Richards, JP Matthews, B.M. Dale, H. Miles Prince	11
2	Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study 2004 ·Bone Marrow Transplantation ·A. Wirth, H. Miles Prince, M Wolf, Janey M. Stone, JP Matthews, John Gibson, Colin Macleod, Jeff Szer, Andrew Grigg, Bik To, Daniel Roos, Anthony P. Schwarer, Susan R. Davis, (unknown)	11
3	Rapid screening for depression – validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients 2004 ·British Journal of Cancer ·Michael Jefford, Linda Mileshkin, Kristy L. Richards, Jasmine Thomson, JP Matthews, John Zalcberg, Ross Jennens, (unknown), Sharon Wein, Yoland Antill, David M. Clarke	36
4	Dose-intensification does not improve outcome in aggressive non-Hodgkin's lymphoma (NHL). Report of a randomized trial by the Australasian Leukemia and Lymphoma Group (ALLG). 2000 ·Blood ·M. Wolf, JP Matthews, J. Stone, (unknown), Peter Browett, G Dart, Ehtesham Abdi, A. Grigg, Jingjin Ding, Howard Gurney, Antonino Bonaventura, Paula Marlton, Ralf Herrmann, David W. Ellis, (unknown)	2
5	Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir 2000 ·Bone Marrow Transplantation ·Christopher Steer, Jeff Szer, Joe Sasadeusz, JP Matthews, (unknown), Andrew Grigg	88
6	A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation 2000 ·Leukemia ·Eduardo Olavarría, Moustapha Hassan, (unknown), Christina Nilsson, Anthony Timms, JP Matthews, Charles Craddock, Edward Kanfer, Jane F. Apperley, John M. Goldman	30
7	A Phase I/II Study of Intensive Dose Escalation of Cytarabine in Combination with Idarubicin and Etoposide in Induction and Consolidation Treatment of Adult Acute Myeloid Leukemia 1999 ·Leukemia & lymphoma ·RM Lowenthal, (unknown), JP Matthews, (unknown), (unknown), Ralph Cobcroft, Paul Eliadis, Arno Enno, Devinder Gill, (unknown), A. Manoharan, (unknown), (unknown), (unknown), Michael Seldon, (unknown), M. Wolf, (unknown)	6
8	Non‐surgical periodontal treatment with and without adjunctive metronidazole in smokers and non‐smokers 1999 ·Journal Of Clinical Periodontology ·RM Palmer, JP Matthews, R. F. Wilson	96
9	Increased survival in patients diagnosed with Hodgkin's disease in Tasmania, 1972–1992 1998 ·Australian and New Zealand Journal of Medicine ·A. H. Strickland, (unknown), JP Matthews, J. Beresford, R. M. Lowenthal	0
10	Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: a controlled clinical study 1998 ·BDJ ·Richard Palmer, JP Matthews, R.F. Wilson	51
11	A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments] 1996 ·Blood ·(unknown), JP Matthews, G. A. R. Young, Jeff Szer, (unknown), D. Joshua, Ken Bradstock, Arno Enno, M. Wolf, R. M. Fox	337
12	Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group. 1994 ·Journal of Clinical Oncology ·I. A. Cooper, M. Wolf, T. I. Robertson, R. M. Fox, JP Matthews, Janey M. Stone, (unknown), G Dart, Frank Firkin	83
13	Failure of intensive chemotherapy in poor prognosis non‐Hodgkin's lymphoma 1992 ·Australian and New Zealand Journal of Medicine ·John Matthews, I. A. Cooper, JP Matthews, (unknown)	4
14	The definition of refractoriness to platelet transfusions 1992 ·Transfusion Medicine ·J. Bishop, JP Matthews, K. Yuen, Kathy McGrath, M. Wolf, Jeff Szer	51
15	A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. 1989 ·Journal of Clinical Oncology ·Brian L. Hillcoat, Derek Raghavan, JP Matthews, Richard Kefford, K. Yuen, (unknown), Ian Olver, James F. Bishop, Bruce Pearson, (unknown)	73
16	Rupture of pectoralis major in weight lifters: a case report and review of the literature 1988 ·Injury ·(unknown), JP Matthews	28
17	Clinical factors influencing the efficacy of pooled platelet transfusions 1988 ·Blood ·(unknown), Kathy McGrath, M. Wolf, JP Matthews, (unknown), Rhonda Holdsworth, K. Yuen, Margaret F. Veale, (unknown), I. A. Cooper	163
18	Clinical factors influencing the efficacy of pooled platelet transfusions 1988 ·Blood ·(unknown), Kathy McGrath, M. Wolf, JP Matthews, (unknown), Rhonda Holdsworth, K. Yuen, Margaret F. Veale, (unknown), I. A. Cooper	12
19	Surgery in acute leukemia: A review of 167 operations in thrombocytopenic patients 1987 ·American Journal of Hematology ·James F. Bishop, CA Schiffer, Joseph Aisner, JP Matthews, P. H. Wiernik	41
20	Posterior Ilio‐psoas Transfer in the Management of the Hip in Spina Bifida: a Review of 34 Operations 1973 ·Developmental Medicine & Child Neurology ·H. Weisl, JP Matthews	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact